Back
SPDR S&P Oil & Gas Exploration & Production ETF Vs. Novo Nordisk AS Industry Stock Comparison
Sell
32
XOP
SPDR S&P Oil & Gas Exploration & Production ETF
Last Price:
$128.35
Seasonality Move:
3.38%
Sell
18
NONOF
Novo Nordisk AS
Last Price:
$87.53
Seasonality Move:
6.72%
Sell
32
SPDR S&P Oil & Gas Exploration & Production ETF (XOP)
is a Sell
Is SPDR S&P Oil & Gas Exploration & Production ETF a Buy, Sell or Hold?
-
The current SPDR S&P Oil & Gas Exploration & Production ETF [XOP] share price is $126.26. The Score for XOP is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
XOP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.86. The Score for NONOF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
XOP Stock Price Chart
What is SPDR S&P Oil & Gas Exploration & Production ETF's stock price today?
-
The SPDR S&P Oil & Gas Exploration & Production ETF share price today is $126.26Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XOP is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.86Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
XOP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.26 | Sell |
Relative Strength Index (14 RSI): | 28.28 | Sell |
Chaikin Money Flow: | 419278 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.63 - 145.67) | Sell |
Bollinger Bands (100): | (131.06 - 141.34) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.61 | Sell |
Relative Strength Index (14 RSI): | 29.63 | Sell |
Chaikin Money Flow: | -16178 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.97 - 111.89) | Sell |
Bollinger Bands (100): | (106.42 - 130.98) | Sell |
XOP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.76 | Sell |
20-day SMA: | 137.98 | Sell |
50-day SMA: | 137.45 | Sell |
200-day SMA: | 142.91 | Sell |
8-day EMA: | 130.64 | Sell |
20-day EMA: | 135.11 | Sell |
50-day EMA: | 137.03 | Sell |
200-day EMA: | 139.43 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102.02 | Sell |
20-day SMA: | 106 | Sell |
50-day SMA: | 108.66 | Sell |
200-day SMA: | 125.92 | Sell |
8-day EMA: | 98.92 | Sell |
20-day EMA: | 103.95 | Sell |
50-day EMA: | 109.19 | Sell |
200-day EMA: | 117.71 | Sell |
SPDR S&P Oil & Gas Exploration & Production ETF Earnings Growth & XOP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
SPDR S&P Oil & Gas Exploration & Production ETF Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |